HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
IFT140
intraflagellar transport 140
Chromosome 16 Β· 16p13.3
NCBI Gene: 9742Ensembl: ENSG00000187535.15HGNC: HGNC:29077UniProt: Q96RY7
46PubMed Papers
24Diseases
0Drugs
233Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingintraciliary anterograde transportcentrosomeciliumshort-rib thoracic dysplasia 9 with or without polydactylycystic kidney diseaseJeune syndromeretinitis pigmentosa
✦AI Summary

IFT140 is a core component of the intraflagellar transport complex A (IFT-A), essential for retrograde ciliary transport and GPCR entry into cilia 12. It plays a pivotal role in ciliogenesis and cilium maintenance across ciliated tissues 2. IFT140 is required for photoreceptor outer segment development and opsin delivery, and recent evidence suggests it protects critical factors in spermiogenesis from proteasomal degradation 3. ARL16 regulates IFT140's export from the Golgi to cilia, indicating its role in ciliary protein trafficking 4. Genetially, IFT140 dysfunction causes diverse ciliopathies reflecting cilia's pleiotropic functions. Biallelic loss-of-function variants cause syndromic short-rib thoracic dysplasia with retinitis pigmentosa, kidney failure, and cardiomyopathy 5. Notably, monoallelic IFT140 variants cause an atypical autosomal dominant polycystic kidney disease phenotype, affecting 1.9-2.1% of ADPKD-diagnosed families 67. This represents the third most common genetic cause of PKD after PKD1/PKD2 6. Affected individuals typically develop large, exophytic kidney cysts with favorable renal prognosis compared to classic ADPKD, though 56.3% over age 60 develop stage 3+ chr16 kidney disease 8. Retinal dystrophy is the most common ocular manifestation across both syndromic and ocular-only IFT140-related phenotypes 9.

Sources cited
1
IFT140 is a component of IFT-A complex required for retrograde ciliary transport and GPCR entry into cilia
PMID: 20889716
2
IFT140 plays pivotal role in ciliogenesis and cilium maintenance; component of IFT-A complex
PMID: 22503633
3
IFT140 is protected from excessive degradation by UBL7 and is essential for manchette development in spermiogenesis
PMID: 40268954
4
ARL16 regulates traffic of IFT140 from Golgi to cilia
PMID: 35196065
5
Monoallelic IFT140 loss-of-function variants cause autosomal dominant polycystic kidney disease in 1.9% of naive families; represents third most common genetic cause after PKD1/PKD2
PMID: 34890546
6
IFT140 loss-of-function variants are associated with ADPKD diagnosis; clinical prevalence confirmed in health system cohort
PMID: 36573973
7
Biallelic IFT140 pathogenic variants cause syndromic ciliopathy with kidney failure, retinal dystrophy, cardiomyopathy, and situs inversus
PMID: 39927556
8
Monoallelic IFT140 variants cause atypical ADPKD with large exophytic cysts; generally favorable kidney prognosis but 56.3% over age 60 have stage 3+ CKD
PMID: 39732359
9
Retinal dystrophy is most common ocular manifestation in IFT140-related ciliopathies; cataracts more common in ocular-only phenotype
PMID: 40774504
Disease Associationsβ“˜24
short-rib thoracic dysplasia 9 with or without polydactylyOpen Targets
0.85Strong
cystic kidney diseaseOpen Targets
0.74Strong
Jeune syndromeOpen Targets
0.69Moderate
retinitis pigmentosaOpen Targets
0.67Moderate
retinitis pigmentosa 80Open Targets
0.66Moderate
urinary system diseaseOpen Targets
0.58Moderate
Retinal dystrophyOpen Targets
0.57Moderate
kidney diseaseOpen Targets
0.57Moderate
Autosomal dominant polycystic kidney diseaseOpen Targets
0.55Moderate
Renal cystOpen Targets
0.55Moderate
Kidney CystOpen Targets
0.52Moderate
ureteral disorderOpen Targets
0.52Moderate
Complex Cyst of KidneyOpen Targets
0.51Moderate
cranioectodermal dysplasia 5Open Targets
0.48Moderate
Joubert syndrome with Jeune asphyxiating thoracic dystrophyOpen Targets
0.48Moderate
genetic disorderOpen Targets
0.45Moderate
Polycystic Kidney DiseaseOpen Targets
0.45Moderate
cranioectodermal dysplasiaOpen Targets
0.43Moderate
disease of genitourinary systemOpen Targets
0.43Moderate
Leber congenital amaurosisOpen Targets
0.41Moderate
Cranioectodermal dysplasia 5UniProt
Polycystic kidney disease 9UniProt
Retinitis pigmentosa 80UniProt
Short-rib thoracic dysplasia 9 with or without polydactylyUniProt
Pathogenic Variants233
NM_014714.4(IFT140):c.2655del (p.Trp885fs)Pathogenic
Retinal dystrophy|Retinitis pigmentosa 80;Saldino-Mainzer syndrome|Saldino-Mainzer syndrome
β˜…β˜…β˜†β˜†2026β†’ Residue 885
NM_014714.4(IFT140):c.634G>A (p.Gly212Arg)Pathogenic
Saldino-Mainzer syndrome|not provided|Jeune thoracic dystrophy|Retinal ciliopathy due to mutation in the retinitis pigmentosa-1 gene|Saldino-Mainzer syndrome;Retinitis pigmentosa 80|Nephronophthisis|IFT140-related disorder|Retinitis pigmentosa 80|Retinal disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 212
NM_014714.4(IFT140):c.2399+1G>TPathogenic
Saldino-Mainzer syndrome|Retinitis pigmentosa 80|Retinal dystrophy|Saldino-Mainzer syndrome;Retinitis pigmentosa 80|not provided|IFT140-related disorder|Autosomal dominant polycystic kidney disease|Polycystic kidney disease|Renal cyst|Polycystic kidney disease 9, susceptibility to|Cystic renal disease
β˜…β˜…β˜†β˜†2026
NM_014714.4(IFT140):c.1377G>A (p.Trp459Ter)Pathogenic
Saldino-Mainzer syndrome|Retinitis pigmentosa|Saldino-Mainzer syndrome;Retinitis pigmentosa 80|IFT140-related disorder|Renal cyst|IFT140-associated disorder|Polycystic kidney disease 9, susceptibility to|Cystic renal disease
β˜…β˜…β˜†β˜†2026β†’ Residue 459
NM_014714.4(IFT140):c.308_309del (p.Thr103fs)Pathogenic
IFT140-related disorder|Saldino-Mainzer syndrome;Retinitis pigmentosa 80|Saldino-Mainzer syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 103
NM_014714.4(IFT140):c.1513C>T (p.Arg505Ter)Pathogenic
Saldino-Mainzer syndrome|not provided|Saldino-Mainzer syndrome;Retinitis pigmentosa 80|Retinitis pigmentosa 80
β˜…β˜…β˜†β˜†2025β†’ Residue 505
NM_014714.4(IFT140):c.1039C>T (p.Arg347Ter)Pathogenic
Saldino-Mainzer syndrome|Retinitis pigmentosa 80;Saldino-Mainzer syndrome|Renal cyst|Retinal dystrophy
β˜…β˜…β˜†β˜†2025β†’ Residue 347
NM_014714.4(IFT140):c.3939C>A (p.Cys1313Ter)Pathogenic
not provided|Retinal dystrophy|Saldino-Mainzer syndrome|Saldino-Mainzer syndrome;Retinitis pigmentosa 80
β˜…β˜…β˜†β˜†2025β†’ Residue 1313
NM_014714.4(IFT140):c.998G>A (p.Cys333Tyr)Pathogenic
Retinitis pigmentosa|Saldino-Mainzer syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 333
NM_014714.4(IFT140):c.168_171del (p.His57fs)Pathogenic
Retinitis pigmentosa 80|Retinitis pigmentosa 80;Saldino-Mainzer syndrome|Saldino-Mainzer syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 57
NM_014714.4(IFT140):c.1010-1G>APathogenic
not provided|Jeune thoracic dystrophy|Saldino-Mainzer syndrome|Retinitis pigmentosa 80|Retinitis pigmentosa|Saldino-Mainzer syndrome;Retinitis pigmentosa 80|Inborn genetic diseases|Acute myeloid leukemia
β˜…β˜…β˜†β˜†2025
NM_014714.4(IFT140):c.1959G>A (p.Trp653Ter)Pathogenic
Saldino-Mainzer syndrome|IFT140-related disorder|Retinal disorder|Saldino-Mainzer syndrome;Retinitis pigmentosa 80
β˜…β˜…β˜†β˜†2025β†’ Residue 653
NM_014714.4(IFT140):c.1451C>T (p.Thr484Met)Pathogenic
Retinitis pigmentosa 80|Retinal dystrophy|Retinitis pigmentosa|Saldino-Mainzer syndrome|Retinitis pigmentosa 80;Saldino-Mainzer syndrome|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 484
NM_014714.4(IFT140):c.1250_1271dup (p.Ser425fs)Pathogenic
Retinal dystrophy|Saldino-Mainzer syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 425
NM_014714.4(IFT140):c.3214C>T (p.Arg1072Ter)Pathogenic
not provided|Saldino-Mainzer syndrome;Retinitis pigmentosa 80|Saldino-Mainzer syndrome|Retinal dystrophy|IFT140-related disorder|Cystic renal disease|Renal cyst
β˜…β˜…β˜†β˜†2025β†’ Residue 1072
NM_014714.4(IFT140):c.2563C>T (p.Gln855Ter)Likely pathogenic
Cranioectodermal dysplasia 5|Retinitis pigmentosa 80;Saldino-Mainzer syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 855
NM_014714.4(IFT140):c.1009+1G>TLikely pathogenic
Saldino-Mainzer syndrome|IFT140-related disorder|Retinitis pigmentosa|Retinitis pigmentosa 80;Saldino-Mainzer syndrome
β˜…β˜…β˜†β˜†2025
NM_014714.4(IFT140):c.1422_1423insAA (p.Arg475fs)Pathogenic
Retinitis pigmentosa 80|Cystic renal disease|Retinitis pigmentosa 80;Saldino-Mainzer syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 475
NM_014714.4(IFT140):c.3874-1G>ALikely pathogenic
Saldino-Mainzer syndrome|Retinitis pigmentosa 80;Saldino-Mainzer syndrome
β˜…β˜…β˜†β˜†2025
NM_014714.4(IFT140):c.2768+1dupPathogenic
IFT140-related disorder|not provided|Renal cyst
β˜…β˜…β˜†β˜†2025
View on ClinVar β†—
Related Genes
IFT27Protein interaction100%IFT46Protein interaction100%IFT22Protein interaction100%IFT52Protein interaction100%DYNC2I1Protein interaction100%DYNC2I2Protein interaction100%
Tissue Expression6 tissues
Ovary
100%
Lung
49%
Brain
43%
Bone Marrow
41%
Heart
30%
Liver
27%
Gene Interaction Network
Click a node to explore
IFT140IFT27IFT46IFT22IFT52DYNC2I1DYNC2I2
PROTEIN STRUCTURE
Preparing viewer…
PDB8BBG Β· 3.50 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.97LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.84 [0.72–0.97]
RankingsWhere IFT140 stands among ~20K protein-coding genes
  • #9,336of 20,598
    Most Researched46
  • #277of 5,498
    Most Pathogenic Variants233 Β· top 10%
  • #9,238of 17,882
    Most Constrained (LOEUF)0.97
Genes detectedIFT140
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 20301590
1.00
2
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
PMID: 34890546
Am J Hum Genet Β· 2022
0.90
3
Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease.
PMID: 36573973
JAMA Β· 2022
0.80
4
PMID: 24027799
0.70
5
PMID: 39990893
Kidney Int Rep Β· 2025
0.60